Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.

Titus MA, Tan JA, Gregory CW, Ford OH, Subramanian RR, Fu H, Wilson EM, Mohler JL, French FS.

Clin Cancer Res. 2009 Dec 15;15(24):7571-7581.

2.

Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis.

Singh SS, Mehedint DC, Ford OH 3rd, Jeyaraj DA, Pop EA, Maygarden SJ, Ivanova A, Chandrasekhar R, Wilding GE, Mohler JL.

Prostate. 2009 Nov 1;69(15):1603-1610. doi: 10.1002/pros.21019.

3.

Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer.

Singh SS, Li Y, Ford OH, Wrzosek CS, Mehedint DC, Titus MA, Mohler JL.

Transl Oncol. 2008 Sep;1(3):153-7.

4.

Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.

Singh SS, Mehedint DC, Ford OH 3rd, Maygarden SJ, Ruiz B, Mohler JL.

Prostate. 2007 Jul 1;67(10):1011-8.

PMID:
17476688
5.

Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.

Majumder S, Liu Y, Ford OH 3rd, Mohler JL, Whang YE.

Prostate. 2006 Sep 1;66(12):1292-301.

PMID:
16705743
6.

Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.

Titus MA, Gregory CW, Ford OH 3rd, Schell MJ, Maygarden SJ, Mohler JL.

Clin Cancer Res. 2005 Jun 15;11(12):4365-71.

7.

Sampling strategy for prostate tissue microarrays for Ki-67 and androgen receptor biomarkers.

Singh SS, Qaqish B, Johnson JL, Ford OH 3rd, Foley JF, Maygarden SJ, Mohler JL.

Anal Quant Cytol Histol. 2004 Aug;26(4):194-200.

PMID:
15457671
8.

The androgen axis in recurrent prostate cancer.

Mohler JL, Gregory CW, Ford OH 3rd, Kim D, Weaver CM, Petrusz P, Wilson EM, French FS.

Clin Cancer Res. 2004 Jan 15;10(2):440-8.

9.

Androgen receptor gene amplification and protein expression in recurrent prostate cancer.

Ford OH 3rd, Gregory CW, Kim D, Smitherman AB, Mohler JL.

J Urol. 2003 Nov;170(5):1817-21.

PMID:
14532783
10.

Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer.

Gaston KE, Kim D, Singh S, Ford OH 3rd, Mohler JL.

J Urol. 2003 Sep;170(3):990-3.

PMID:
12913756
11.

Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer.

Mohler JL, Morris TL, Ford OH 3rd, Alvey RF, Sakamoto C, Gregory CW.

Prostate. 2002 Jun 1;51(4):247-55.

PMID:
11987153
12.

Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.

Wu D, Foreman TL, Gregory CW, McJilton MA, Wescott GG, Ford OH, Alvey RF, Mohler JL, Terrian DM.

Cancer Res. 2002 Apr 15;62(8):2423-9.

13.

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS, Wilson EM.

Cancer Res. 2001 Jun 1;61(11):4315-9.

Supplemental Content

Support Center